Table 4 Correlation of SII and other clinical, pathological factors
Variable | SII ≤ 470 | SII > 470 | P value |
|---|---|---|---|
N = 103 | N = 92 | ||
Gender | |||
 Female | 61 (59.2%) | 50 (54.3%) | 0.492 |
 Male | 42 (40.8%) | 42 (45.7%) | |
Age | |||
  > 65 | 62 (60.2%) | 53 (57.6%) | 0.714 |
  ≤ 65 | 41 (39.8%) | 39 (42.4%) | |
Hypertension history | |||
 No | 52 (50.5%) | 48 (52.2%) | 0.814 |
 Yes | 51 (49.5%) | 44 (47.8%) | |
Diabetes history | |||
 No | 83 (80.6%) | 75 (81.5%) | 0.867 |
 Yes | 20 (19.4%) | 17 (18.5%) | |
BMI | |||
  < 24 | 42 (40.8%) | 46 (50.0%) | 0.196 |
  ≥ 24 | 61 (59.2%) | 46 (50.0%) | |
Tumor side | |||
 Left | 57 (55.3%) | 45 (48.9%) | 0.370 |
 Right | 46 (44.7%) | 47 (51.1%) | |
Location | |||
 Both | 22 (21.4%) | 18 (19.6%) | 0.702 |
 Renal pelvis | 39 (37.9%) | 31 (33.7%) | |
 Ureter | 42 (40.8%) | 43 (46.7%) | |
Tumor size | |||
  > 3 | 34 (33.0%) | 37 (40.2%) | 0.296 |
  ≤ 3 | 69 (67.0%) | 55 (59.8%) | |
Tumor stage | |||
  ≤ 2 | 77 (74.8%) | 69 (75.0%) | 0.969 |
  ≥ 3 | 26 (25.2%) | 23 (25.0%) | |
Neural or vascular invasion | |||
 No | 93 (90.3%) | 73 (79.3%) | 0.032 |
 Yes | 10 (9.71%) | 19 (20.7%) | |
Renal sinus invasion | |||
 No | 91 (88.3%) | 83 (90.2%) | 0.674 |
 Yes | 12 (11.7%) | 9 (9.78%) | |
Pararenal invasion | |||
 No | 91 (88.3%) | 78 (84.8%) | 0.464 |
 Yes | 12 (11.7%) | 14 (15.2%) | |
Mucosa invasion | |||
 No | 90 (87.4%) | 69 (75.0%) | 0.026 |
 Yes | 13 (12.6%) | 23 (25.0%) | |
Subepithelial invasion | |||
 No | 97 (94.2%) | 90 (97.8%) | 0.357 |
 Yes | 6 (5.83%) | 2 (2.17%) | |
Muscle invasion | |||
 No | 65 (63.1%) | 44 (47.8%) | 0.032 |
 Yes | 38 (36.9%) | 48 (52.2%) | |
Fat invasion | |||
 No | 95 (92.2%) | 71 (77.2%) | 0.003 |
 Yes | 8 (7.77%) | 21 (22.8%) | |
Cancer embolus | |||
 No | 94 (91.3%) | 76 (82.6%) | 0.071 |
 Yes | 9 (8.74%) | 16 (17.4%) | |
Ureteral ends invasion | |||
 No | 101 (98.1%) | 87 (94.6%) | 0.356 |
 Yes | 2 (1.94%) | 5 (5.43%) | |
Lymph node invasion | |||
 No | 101 (98.1%) | 87 (94.6%) | 0.356 |
 Yes | 2 (1.94%) | 5 (5.43%) | |
Hydronephrosis | |||
 No | 67 (65.0%) | 57 (62.0%) | 0.654 |
 Yes | 36 (35.0%) | 35 (38.0%) | |
Urine cytology | |||
 Abnormal | 54 (52.4%) | 58 (63.0%) | 0.134 |
 Normal | 49 (47.6%) | 34 (37.0%) | |
Ureteroscopy | |||
 No | 44 (42.7%) | 38 (41.3%) | 0.842 |
 Yes | 59 (57.3%) | 54 (58.7%) | |
ALT/AST | |||
  > 0.55 | 67 (65.0%) | 70 (76.1%) | 0.092 |
  ≤ 0.55 | 36 (35.0%) | 22 (23.9%) | |
eGFR | |||
  < 60 | 68 (66.0%) | 62 (67.4%) | 0.839 |
  ≥ 60 | 35 (34.0%) | 30 (32.6%) | |
Tumor size | |||
  > 3 | 34 (33.0%) | 37 (40.2%) | 0.296 |
  ≤ 3 | 69 (67.0%) | 55 (59.8%) | |
Tumor grade | |||
 High | 87 (84.5%) | 88 (95.7%) | 0.020 |
 Low | 16 (15.5%) | 4 (4.35%) | |